Natural-based Sweeteners - DOLCE core team announces membership changes in programme for natural-based sweeteners
DGAP-News: B.R.A.I.N. Biotechnology Research And Information Network AG / Key word(s): Miscellaneous
Zwingenberg, Potsdam (Germany)
New industry partners are invited to join DOLCE, allowing them to test the natural-based sweetening solutions early in the development phase directly within their specific product matrixes for their own product portfolio. For non-exclusive members of the partnership the business model was reshaped to enable the new members an easier access to the programme.
The goal of the DOLCE partnership is providing next generation natural-based sweetening solutions for healthier food and beverages. Since the launch of the programme in August 2016 significant product categories were selected. The core team is currently preparing new partnerships for available product categories and negotiations with potential members.
Sergio Neves, Head of Nutrition and Health R&D at Roquette Group, says: "DOLCE is a great program. At the beginning of this year, we reached an important milestone by identifying and characterizing a number of natural-based sweet taste enhancers and high intensity sweeteners which we can share with members of the partnership."
Martin Langer, EVP Corporate Development at BRAIN, says: "The DOLCE programme is moving forward with high business potential for all parties involved. We continue to invite further CPGCs to join our ongoing successful programme."
Lutz Müller-Kuhrt, CEO of AnalytiCon Discovery states: "During the last two years we made good progress in the programme. We started with 50 natural sweetener candidates, now identified another 20, many of them new and already applied for patent by the team. We are happy to provide this collection of molecules to our DOLCE members and help them to reduce the sugar load in their products."
For additional information on joining the DOLCE programme, please contact:
B.R.A.I.N. Biotechnology Research and Information Network AG (BRAIN AG; ISIN DE0005203947 / WKN 520394) is one of Europe's leading technology companies in the field of industrial biotechnology, the core discipline of Bioeconomy. As such, BRAIN identifies previously untapped, efficient enzymes, microbial producer organisms or natural substances from complex biological systems that can be put to industrial use. The innovative solutions and products developed by help of this "Toolbox of Nature" are successfully applied in the chemistry, the cosmetics and the food industries. BRAIN's business model is based on two pillars - BioScience and BioIndustrial. The BioScience comprises its frequently exclusive collaboration business with industrial partners. BioIndustrial comprises the development and commercialization of BRAIN's own products and active product components. Further information is available at www.brain-biotech.de/en.
AnalytiCon Discovery GmbH is a global market leader in the area of compound libraries containing fully analyzed structures. Located on the Potsdam Biotech Campus, the company offers services for every stage of the supply chain for natural product-based (NP-based) substance discoveries and developments. Innovative technology concepts enable high-grade partnerships with globally operating companies from the pharmaceutical, food manufacturing and cosmetics industries. AnalytiCon Discovery enjoys access to around 15 percent of all natural compounds known worldwide, as well as to thousands of structures that have not yet been published. AnalytiCon Discovery has been a member of the BRAIN Group since 2013. Further information is available at www.ac-discovery.com.
Roquette is a global leader in plant-based ingredients and a pioneer of new vegetal proteins. In collaboration with its customers and partners, the Group addresses current and future societal challenges by unlocking the potential of Nature to offer the best ingredients for Food, Nutrition and Health markets. Each of these ingredients responds to unique and essential needs, and they enable healthier lifestyles. Thanks to a constant drive for innovation and a long-term vision, the Group is committed to improving the well-being of millions of people all over the world while taking care of resources and territories. Roquette currently operates in over 100 countries, has a turnover of around 3.2 billion euros and employs 8,300 people worldwide. Further information is available at www.roquette.com.
|Company:||B.R.A.I.N. Biotechnology Research And Information Network AG|
|Darmstädter Straße 34-36|
|Phone:||+49 (0) 62 51 / 9331-0|
|Fax:||+49 (0) 62 51 / 9331-11|
|Listed:||Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange|
|End of News||DGAP News Service|